Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong
· Delayed Price · Currency is HKD 26.50
+0.40 (1.53%)
Apr 24, 2025, 4:08 PM HKT
HKG:1501 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 851.95 | 752.84 | 585.88 | 464.68 | 358.43 | Upgrade
|
| Revenue Growth (YoY) | 13.17% | 28.50% | 26.08% | 29.64% | 25.12% | Upgrade
|
| Cost of Revenue | 314.29 | 314.77 | 253.4 | 188.93 | 124.01 | Upgrade
|
| Gross Profit | 537.66 | 438.07 | 332.49 | 275.75 | 234.42 | Upgrade
|
| Selling, General & Admin | 200.23 | 166.82 | 120.68 | 79.07 | 57.44 | Upgrade
|
| Research & Development | 149.13 | 125.85 | 99.63 | 89.96 | 64.59 | Upgrade
|
| Other Operating Expenses | -23.1 | -17 | -18.1 | -38.49 | -12.97 | Upgrade
|
| Operating Expenses | 325.64 | 276.08 | 203.14 | 131.11 | 109.07 | Upgrade
|
| Operating Income | 212.02 | 161.99 | 129.34 | 144.64 | 125.35 | Upgrade
|
| Interest Expense | -2.43 | -3.19 | -0.82 | -0.63 | -0.09 | Upgrade
|
| Interest & Investment Income | 9.11 | 11.83 | 13.41 | 14.53 | 24.1 | Upgrade
|
| Earnings From Equity Investments | -0.4 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 3.11 | 2.42 | 2.54 | -2.84 | -12.31 | Upgrade
|
| EBT Excluding Unusual Items | 221.41 | 173.05 | 144.47 | 155.69 | 137.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | -8.03 | 2.08 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | 0.04 | Upgrade
|
| Pretax Income | 213.38 | 175.13 | 144.47 | 155.69 | 137.09 | Upgrade
|
| Income Tax Expense | 23.34 | 21.9 | 10.64 | 15.25 | 20.57 | Upgrade
|
| Earnings From Continuing Operations | 190.05 | 153.23 | 133.83 | 140.45 | 116.52 | Upgrade
|
| Minority Interest in Earnings | 1.87 | 3.23 | -2.12 | 2.52 | 4.84 | Upgrade
|
| Net Income | 191.91 | 156.46 | 131.71 | 142.96 | 121.35 | Upgrade
|
| Preferred Dividends & Other Adjustments | 11 | 4.58 | 1.57 | - | - | Upgrade
|
| Net Income to Common | 180.92 | 151.88 | 130.15 | 142.96 | 121.35 | Upgrade
|
| Net Income Growth | 22.66% | 18.79% | -7.87% | 17.80% | 21.82% | Upgrade
|
| Shares Outstanding (Basic) | 165 | 166 | 166 | 166 | 166 | Upgrade
|
| Shares Outstanding (Diluted) | 171 | 171 | 169 | 167 | 166 | Upgrade
|
| Shares Change (YoY) | -0.11% | 1.10% | 1.32% | 0.48% | 31.04% | Upgrade
|
| EPS (Basic) | 1.10 | 0.92 | 0.78 | 0.86 | 0.73 | Upgrade
|
| EPS (Diluted) | 1.10 | 0.92 | 0.78 | 0.86 | 0.73 | Upgrade
|
| EPS Growth | 20.10% | 17.49% | -9.38% | 17.81% | -7.17% | Upgrade
|
| Free Cash Flow | 99.8 | 9.31 | -62.75 | -205.07 | 7.92 | Upgrade
|
| Free Cash Flow Per Share | 0.58 | 0.05 | -0.37 | -1.23 | 0.05 | Upgrade
|
| Dividend Per Share | - | 0.270 | 0.240 | 0.260 | 0.285 | Upgrade
|
| Dividend Growth | - | 12.50% | -7.69% | -8.77% | 62.86% | Upgrade
|
| Gross Margin | 63.11% | 58.19% | 56.75% | 59.34% | 65.40% | Upgrade
|
| Operating Margin | 24.89% | 21.52% | 22.08% | 31.13% | 34.97% | Upgrade
|
| Profit Margin | 21.24% | 20.18% | 22.21% | 30.77% | 33.86% | Upgrade
|
| Free Cash Flow Margin | 11.71% | 1.24% | -10.71% | -44.13% | 2.21% | Upgrade
|
| EBITDA | 286.75 | 204.78 | 159.99 | 168.81 | 143.23 | Upgrade
|
| EBITDA Margin | 33.66% | 27.20% | 27.31% | 36.33% | 39.96% | Upgrade
|
| D&A For EBITDA | 74.73 | 42.79 | 30.65 | 24.17 | 17.88 | Upgrade
|
| EBIT | 212.02 | 161.99 | 129.34 | 144.64 | 125.35 | Upgrade
|
| EBIT Margin | 24.89% | 21.52% | 22.08% | 31.13% | 34.97% | Upgrade
|
| Effective Tax Rate | 10.94% | 12.50% | 7.36% | 9.79% | 15.00% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.